Electronic Pediatric Emergency Ruler vs the Broselow Tape. (ePERvsBT)

Electronic Pediatric Emergency Ruler vs the Broselow Tape in a Simulated Pediatric Emergency Scenario

Comparison of two different pediatric emergency rulers for length-based body weight estimation in pediatric emergencies.

Primary outcome is the time needed to identify four defined parameters from the pediatric emergency rulers during a low-fidelity pediatric emergency scenario (cardiac arrest). Secondary outcome is the correctness of the identified parameters and the percentage deviation from the correct value.

Study Overview

• Status: Completed
• Conditions: Time Until Identification of Defined Parameter
• Intervention / Treatment: Device: ePER; Device: BT

Detailed Description

Medical team members (Paramedics, EMT) of Schutz und Rettung Zurich, Zurich Switzerland were asked to participate in this study. If they were not familiar with one of the three devices written informed consent was obtained and the participant included in this study. This exclusion criteria was necessary to prevent a bias by already knowing where to find the information of interest.

The pediatric emergency rulers investigated were the electronic Pediatric Emergency Ruler (ePER) and the Broselow Tape (BT)

All participants were instructed for the use of the two pediatric emergency rulers and were given time to practice with each device using one training manikin (Sim-Baby)

After they felt comfortable using the devices the participants were randomly assigned to use each device only once with one of two different manikins:

Resusci Baby, Laerdal/Dräger Medical Switzerland AG, Liebefeld, Switzerland Ambu® Junior, Ambu® GmbH, Bad Nauheim, Germany

Each manikin was only used once for the same participant. This guaranteed that the participants were blinded for the manikins.

The low-fidelity pediatric emergency scenario simulated was a cardiac arrest and the participants were asked to identify the following information from the pediatric emergency rulers:

Estimated body weight Joule suggested for defibrillation Recommended epinephrine dose Suggested endotracheal tube size

Participants stood aside from the manikin with a pediatric emergency ruler in their hand. After they stated they were ready, the facilitator started a countdown from three and gave the command to start. This setting was identical for all two pediatric emergency rulers and all two manikins. The time until each parameter was identified and the value of the parameter were recorded.

Primary outcome was the time needed to identify the four above defined parameters. Secondary outcome was the correctness of the identified parameters and the percentage deviation from the correct value.

• Study Type: Observational
• Enrollment (Actual): 20

Contacts and Locations

Study Locations

• Switzerland
  • Zurich, Switzerland, 8032
    • University Childrens Hospital, Department of Anaesthesia and Children's Research Centre

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Medical team members (Paramedics, EMT) of Schutz und Rettung Zurich, Zurich, Switzerland

Description

Inclusion Criteria:

• Medical team members (Paramedics, EMT) of Schutz und Rettung Zurich, Zurich, Switzerland
• Written informed consent

Exclusion Criteria:

• Having worked with one of the pediatric emergency rulers and knowing where to find the defined parameters

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Prospective

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Resusci Baby; Resusci Baby used for the simulated emergency scenario	Device: ePER; usind the ePER for weight estimation and suggestion of the defined parameter; Device: BT; usind the BT for weight estimation and suggestion of the defined parameter
Ambu® Junior; Ambu® Junior used for the simulated emergency scenario	Device: ePER; usind the ePER for weight estimation and suggestion of the defined parameter; Device: BT; usind the BT for weight estimation and suggestion of the defined parameter

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time to identification	Time needed to identify the four defined parameters	During simulation, approximately 30 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Correctness	Correctness of the identified Parameter. The from the participant identified value is compared with the per value defined correctly based on the manikin size.	During simulation, approximately 30 minutes
Percentage deviation	If the Parameter was identified incorrectly, a percentage deviation of the identified value from the correct value will be calculated	During simulation, approximately 30 minutes

Collaborators and Investigators

• Sponsor: University Children's Hospital, Zurich
• Investigators: Principal Investigator: Alexander R Schmidt, MD, Department of Anaesthesia and Children's Research Centre, University Children's Hospital, Zurich, Switzerland

Study record dates

Study Major Dates

• Study Start (Actual): January 5, 2019
• Primary Completion (Actual): February 8, 2019
• Study Completion (Actual): February 20, 2019

Study Registration Dates

• First Submitted: May 14, 2019
• First Submitted That Met QC Criteria: May 14, 2019
• First Posted (Actual): May 16, 2019

Study Record Updates

• Last Update Posted (Actual): May 20, 2019
• Last Update Submitted That Met QC Criteria: May 17, 2019
• Last Verified: May 1, 2019

More Information

Terms related to this study

• Keywords: Patient safety; Weight estimation
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: ePER vs BT

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No